The conserved N-terminal SANT1-binding domain (SBD) of EZH2 regulates PRC2 activity
Genes & Development · 2026
DOI: 10.1101/gad.353070.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, 2026. Verfasst von Agata L Patriotis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, New York 10065, USA; alpat@mit.edu. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Polycomb Repressive Complex 2. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NICHD NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Polycomb group proteins maintain gene expression patterns established during early development, with Polycomb repressive complex 2 (PRC2) methyltransferase being a key regulator of cell differentiation, identity, and plasticity. Consequently, extensive somatic mutations in PRC2, including gain or loss of function (GOF or LOF), are observed in human cancers. The regulation of chromatin structure by PRC2 is critically dependent on its enhancer of zeste homolog 2 (EZH2) subunit, which catalyzes the methylation of histone H3 lysine 27 (H3K27). Recent structural studies of PRC2 revealed extensive conformational changes in the noncatalytic EZH2 N-terminal SANT1-binding domain (SBD) during PRC2 activation, though the functional significance remains unclear. Here, we investigated how the SBD regulates PRC2 function. The domain is highly conserved in metazoans and dispensable for PRC2 assembly and chromatin localization yet is required for genome-wide histone H3K27 methylation. Furthermore, we show that an intact SBD is necessary for the proliferation of EZH2-addicted lymphomas, and its deletion in the presence of EZH2 GOF mutations inhibits cancer cell growth. These observations provide new insights into the regulation of PRC2 activity in normal development and malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, New York 10065, USA; alpat@mit.edu.
- Bioinformatics Resource Center, The Rockefeller University, New York, New York 10065, USA.
- Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, New York 10065, USA.
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
- EpiCypher, Inc., Durham, North Carolina 27709, USA.
- Epigenetics Institute, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
ORCID-Profile: Agata L Patriotis, Douglas W Barrows, Yadira Soto-Feliciano, Laiba F Khan, Marylene Leboeuf, Dylan M Marchione, Matthew R Marunde, Michael-Christopher Keogh, Alexey A Soshnev
Förderung
- NIGMS NIH HHS
- NICHD NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
- Women and Science Fellowship Anderson Cancer Center Fellowship for Cancer Research
- National Cancer Institute
- Damon Runyon-Sohn Pediatric Cancer Fellowship
Zitieren
APA
Patriotis, A. L., Barrows, D. W., Soto-Feliciano, Y., Khan, L. F., Leboeuf, M., Marchione, D. M., Marunde, M. R., Keogh, M. C., Carroll, T. S., Garcia, B. A., Soshnev, A. A., & Allis, C. D. (2026). The conserved N-terminal SANT1-binding domain (SBD) of EZH2 regulates PRC2 activity. Genes & Development. https://doi.org/10.1101/gad.353070.125
Vancouver
Patriotis AL, Barrows DW, Soto-Feliciano Y, Khan LF, Leboeuf M, Marchione DM, et al. The conserved N-terminal SANT1-binding domain (SBD) of EZH2 regulates PRC2 activity. Genes & Development. 2026. doi:10.1101/gad.353070.125
BibTeX
@article{Patriotis2026,
author = {Patriotis, Agata L and Barrows, Douglas W and Soto-Feliciano, Yadira and Khan, Laiba F and Leboeuf, Marylene and Marchione, Dylan M and Marunde, Matthew R and Keogh, Michael-Christopher and Carroll, Thomas S and Garcia, Benjamin A and Soshnev, Alexey A and Allis, C David},
title = {The conserved N-terminal SANT1-binding domain (SBD) of EZH2 regulates PRC2 activity},
journal = {Genes & Development},
year = {2026},
doi = {10.1101/gad.353070.125}
}
EUVIMED